Description
Teleflex Central Venous Catheter Kit Arrow 18 Fr. Double Lumen
This Central Venous Catheter Kit from Arrow is ideal for infusion and vascular access procedures. Supplied sterile. Sold by the case of 5.
| MF Id# | CDC-12802-1A |
| Brand | Arrow |
| Manufacturer | Teleflex |
| Country of Origin | Unknown |
| Application | Central Venous Catheter Kit |
| Contents 1 | 1) Two-Lumen Catheter: 8 Fr. (2.8 mm OD) x 16 cm, (1) Spring-Wire Guide, Marked: .032 Inch (0.81 mm) dia. x 17-3/4 Inch (45 cm) (Straight Soft Tip on One End - "J" Tip on Other) with Arrow Advancer, (1) Catheter: 18 Ga. X 2-1/2 Inch (6.35 cm) Radiopaque over 20 Ga. RW Introducer Needle, (1)Injection Needle: SafetyGlide™1 25 Ga. X 1 Inch (2.54 cm), (1) Blunt Fill Needle: 18 Ga. x 1-1/2 Inch (3.81 cm), (1) Pressure Transduction Probe, (1) Introducer Needle: Echogenic 18 Ga. X 2-1/2 Inch (6.35 cm) XTW and 5 mL Arrow® Raulerson Spring-Wire Introduction Syringe, (1) Injection Needle: SafetyGlide™1 22 Ga. X 1-1/2 Inch (3.81 cm) and 5 mL Luer-Slip Syringe, (1) Syringes: 3 mL Luer-Lock, (1) Tissue Dilator: 9 Fr. (3.0 mm) X 10.2 cm, (1) 5 mL 1% Lidocaine HCl Solution and Alcohol Prep, (1) 3 mL Applicator 2% CHG and 70% IPA ChloraPrep®2 One-Step Solution with Hi-Lite Orange™ Tint, (1) SecondSite™ Adjustable Hub: Fastener, (1) SecondSite™ Adjustable Hub: Catheter Clamp, (1) SharpsAway® Disposal Cup, (1) SharpsAway® II Locking Disposal Cup, (1) Maximal Barrier Drape™ with 4 Inch Fenestration, (1) Needle Holder, (1) Safety Scalpel: #11, (1) Checklist/CLIP Sheet, (1) Sterile Procedure Sign, (1) Medication Label: 1% Lidocaine, (2) 2 X 2 Inch Gauze Pad, (5) 4 X 4 Inch Gauze Pad, (1) Surgical Apparel: Impervious Gown, (1) Surgical Apparel: Bouffant Cap, (1) Surgical Apparel: Mask with Eye Shield, (1) Suture: 3-0 Silk with Curved Needle, (1) HemoHopper® Fluid Receptacle |
| Diameter | 18 Fr. |
| Length | 16 cm |
| Sterility | Sterile |
| Tube Type | Double Lumen |
| UNSPSC Code | 42221509 |
| Usage | Single Use |
| User | Adult |
Features
- The Arrow catheter is indicated to permit short-term (< 30 day) central venous access for the treatment of diseases or conditions requiring central venous access,

